Loading…
Risk of infections and cardiovascular and venous thromboembolic events associated with JAK inhibitors in rheumatoid arthritis: protocols of two systematic reviews and network meta-analyses
INTRODUCTION: Janus kinases (JAK) inhibitors demonstrated to be effective in the treatment of adult patients with moderate-to-severe active rheumatoid arthritis (RA) but have been associated with serious cardiovascular and serious events. Two systematic reviews and network meta-analyses will be carr...
Main Authors: | , , , |
---|---|
Format: | Online Article Text |
Language: | English |
Published: |
BMJ Publishing Group
2020
|
Subjects: | |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780510/ https://www.ncbi.nlm.nih.gov/pubmed/33384392 http://dx.doi.org/10.1136/bmjopen-2020-041420 |